Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021

The aim of this review is to update the current status of allogeneic hemopoietic stem cell transplants (HSCT) for patients with myelofibrosis (MF). We have first summarized the issue of an indication for allogeneic HSCT, discussing several prognostic scoring systems, developed to predict the outcome...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Immunol
Main Authors: Bacigalupo, Andrea, Innocenti, Idanna, Rossi, Elena, Sora, Federica, Galli, Eugenio, Autore, Francesco, Metafuni, Elisabetta, Chiusolo, Patrizia, Giammarco, Sabrina, Laurenti, Luca, Benintende, Giulia, Sica, Simona, De Stefano, Valerio
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2021
Teme:
Immunology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8129535/
https://ncbi.nlm.nih.gov/pubmed/34017327
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.637512
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki